Figure 2

AML1/ETO expression regulates motility and adhesion of hematopoietic and leukemic cells.
(A) Transwell migration assay of EML-EV control and EML-AE22 cell with (grey bars) or without (black bars) the addition of SDF1 to the lower chamber. (B) Western Blot analysis of AML1/ETO protein expression upon shRNA-mediated interference in Kasumi-1 and SKNO-1 cell lines. Vinculin was used as loading control. (C) Transwell migration assay on Kasumi-1 and SKNO-1 cells upon AML1/ETO interference (shAE). (D) RNA-seq track of EML-EV control cells and EML-AE22 cells at the Cxcr4 gene locus. The two biological replicates used for sequencing are shown (rep1 and rep2). (E) Cxcr4 expression levels were measured by RT-qPCR in EML-EV and EML-AE22 cells. Levels are relative to Tbp expression and normalized for expression in the control cells. (F) Adhesion assay of EML-EV and EML-AE22 cells on primary murine bone marrow stroma and ATF024 cell lines. (G) Adhesion properties of Kasumi-1 and SKNO-1 human AML cell line after AML1/ETO interference (shAE) on ATF024 cells.